When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is ...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few ...

February 4, 2026Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GISTNovel Mechanism of ...

The Ontario Physicians and Surgeons Discipline Tribunal ruled Jan. 28 that Ashwin Rajan Maharaj demonstrated incompetence and engaged in disgraceful, dishonourable and unprofessional conduct in his ...

Shares Core Dividend Growth ETF is upgraded to Strong Buy due to quality dividend growers and strong cash flows. Read more about DGRO ETF here.

Beacon Securities analyst Russell Stanley notes that a sharp acceleration in defense-sector capital spending is underway ...

“Before you ask, there is nothing extreme about 5% of my ‘alternative’ assets.” ...

The Direxion Daily MSCI Emerging Markets Bull 3x Shares ETF offers 3x leveraged daily exposure to the MSCI Emerging Markets Index. Click for more on EDC ETF.

Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector ...

February 4, 2026 Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST Novel Mechanism of Action Shown to be Effective in TKI Resistant PDX Models ...

A recent episode of HBO's 'The Pitt' tackles generative AI in medicine, getting some things right, some wrong and leaving out ...